RBBP4 and neuroblastoma: Log-rank test of 42 NB cases revealed that patients with high RBBP4 levels had poorer survival probability (P = 5.0×10−4, log-rank test) than those with low levels (Supplementary Fig. 9e), which was consistent with the findings from public dataset (GSE16476, Supplementary Fig. 9e).